# The Effect of IV Cangrelor and Oral Ticagrelor Study

Study · id `cardio:ct-nct02733341` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02733341](<https://clinicaltrials.gov/study/NCT02733341>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02733341

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02733341. Randomized; no masking; primary purpose treatment. Start 2016-07-21 (actual); primary completion 2018-10-01 (actual). Results posted on 2025-05-02.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02733341, source copy `cardio:ctgov-nct02733341-2025-05-02`, retrieved 2026-10-26)
- Started: 2016-07-21 (actual) (ClinicalTrials.gov record NCT02733341, source copy `cardio:ctgov-nct02733341-2025-05-02`, retrieved 2026-10-26)
- Primary completion: 2018-10-01 (actual) (ClinicalTrials.gov record NCT02733341, source copy `cardio:ctgov-nct02733341-2025-05-02`, retrieved 2026-10-26)
- Completion: 2018-10-01 (actual) (ClinicalTrials.gov record NCT02733341, source copy `cardio:ctgov-nct02733341-2025-05-02`, retrieved 2026-10-26)
- Results first posted: 2025-05-02 (ClinicalTrials.gov record NCT02733341, source copy `cardio:ctgov-nct02733341-2025-05-02`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02733341, source copy `cardio:ctgov-nct02733341-2025-05-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02733341-2025-05-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of IV Cangrelor and Oral Ticagrelor Study
- Condition: Acute Coronary Syndrome (ACS)
- Condition: High On-treatment Platelet Reactivity (HTPR)
- Condition: Microvascular Obstruction (MVO)
- Condition: ST-segment Elevation Myocardial Infarction (STEMI)
- Condition: Thrombolysis in Myocardial Infarction (TIMI)
- Condition: Unstable Angina (UA)
- Intervention (Drug): Cangrelor
- Intervention (Drug): Ticagrelor
- Lead sponsor: The Royal Wolverhampton Hospitals NHS Trust
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial (`cardio:pubmed-31129911`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c40b4091e696958d2c8d0ac4d865dc0b7efd07778c367085c8ab9719c58155ff
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
